Ключевые слова
Как цитировать
Аннотация
Обобщены данные литературы, посвящённые эффективности скрининга онкологических заболеваний. На основании результатов широкого спектра исследований сделаны выводы о возможностях и ограничениях внедрения различных методов диагностики, а также обсуждены перспективы развития скрининга различных локализаций. Дана качественная оценка исследованиям. Сделаны выводы об эффективности скрининга рака шейки матки, колоректального рака и рака молочной железы. Представлена интерпретация результатов исследований эффективности скрининга рака предстательной железы, рака лёгкого и комбинированной программы скрининга и профилактики рака желудка. Приведены отрицательные результаты исследований скрининга других локализаций, а также обозначены пути развития методов диагностики этих заболеваний с целью создания эффективных программ скрининга.
Библиографические ссылки
Вагнер Р.И., Позмогов А.И., Шумаков А.Г и др. Организация раннего выявления рака легкого//Вопросы онкологии. -1982. -№ 2 (28). -С. 28-33.
Каприн А.Д., Старинский В.В., Петрова ГВ. Злокачественные образования в России в 2015 году (заболеваемость и смертность)/А.Д. Каприн, В.В. Старинский, ГВ. Петрова. -М.: МНИОИ им. ПА Гер-цена-филиал, 2017.
Aghoram R., Cai P, Dickinson J.A. Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B//The Cochrane database of systematic reviews. -2012. -№ 9 (22). -P. CD002799.
Andriole G.L., Crawford E.D., Grubb R.L. et al. Mortality results from a randomized prostate-cancer screening trial//New England Journal of Medicine. -2009. -№ 13 (360). -P 1310-1319.
Anttila A., Pokhrel A., Kotaniemi-Talonen L. et al. Cervical cancer patterns with automation-assisted and conventional cytological screening: a randomized study//International Journal of Cancer. -2011. -№ 5 (128). -P. 1204-1212.
Archer D.F., Mclntyre-Seltman K., Wilborn W.W. et al. Endometrial morphology in asymptomatic postmenopausal women//American journal of obstetrics and gynecology. -1991. -№ 2 (165). -P 317-20-discussion 320-2.
Aste H., Saccomanno S., Munizzi F. Blind pan-esophageal brush cytology. Diagnostic accuracy//Endoscopy. -1984. -№ 5 (16). -P 165-167.
Auvinen A., Hakama M. Cancer Screening: Theory and Applications Elsevier, 2014.
Boniol M., Autier P., Gandini S. Melanoma mortality following skin cancer screening in Germany//BMJ open.-2015. -№ 9 (5). -P e008158.
Cozzi D.A., Mele E., Ceccanti S. et al. Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma//World journal of surgery. -2013. -№ 2 (37). -P 459-465.
de Koning H.J., Meza R., Plevritis S.K. et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force//Annals of Internal Medicine. -2014. -№ 5 (160). -P 311-320.
Diederich S., Thomas M., Semik M. et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers//European Radiology. -2004. -№ 4 (14). -P 691-702.
Dodd G.D., Miller W.J., Baron R.L., et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique//American Journal of Roentgenology. -1992. -№ 4 (159). -P. 727-733.
Faivre J., Dancourt V., Lejeune C., et al. Reduction in colorectal cancer mortality by fecal occult blood screen ing in a French controlled study//Gastroenterology. -2004. -№ 7 (126). -P 1674-1680.
Fuller C., Camilon R., Nguyen S. et al. Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: Systematic review with meta-analysis//Head & neck. -2015. -№ 5 (37). -P 755-762.
Fung M.F.K., Reid A., Faught W. et al. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen//Gynecologic Oncology. -2003. -№ 1 (91). -P 154-159.
Gronberg H., Adolfsson J., Aly M. et al. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study//The Lancet Oncology. -2015. -№ 16 (16). -P 16671676.
Hakama M., Pokhrel A., Malila N. et al. Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre-invasive phase//International Journal of Cancer. -2015. -№ 4 (136). -P 928-935.
Hamdy F.C., Donovan J.L., Lane J.A. et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer//New England Journal of Medicine. -2016. -№ 15 (375). -P 1415-1424.
Hayata Y, Funatsu H., Kato H. et al. Results of Lung Cancer Screening Programs in Japan Recent Results in Cancer Research. -Berlin, Heidelberg: Springer Berlin Heidelberg, 1982. -P. 163-173.
Hayes S.A., Haefliger S., Harris B. et al. Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers//Journal of Breath Research. -2016. -№ 3 (10). -P 034001.
Hewitson P., Glasziou P., Watson E. et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update//The American Journal of Gastroenterology. -2008. -№ 6 (103). -P. 1541-1549.
Holme., Lberg M., Kalager M., et al. Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Randomized Clinical Trial//JAMA. -2014. -№ 6 (312). -P. 606-615.
Horeweg N., van der Aalst C.M., Thunnissen E. et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial//American Journal of Respiratory and Critical Care Medicine. -2013. -№ 8 (187). -P. 848-854.
Imperiale T.F., Ransohoff D.F., Itzkowitz S.H. et al. Multitarget stool DNA testing for colorectal-cancer screening//New England Journal of Medicine. -2014. -№ 14 (370). -P. 1287-1297.
Investigators T.I.E.L.C.A.P Survival of Patients with Stage I Lung Cancer Detected on CT Screening. -2008. -P. 1-9.
Jacobs I.J., Menon U., Ryan A. et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial//The Lancet. -2016. -№ 10038 (387). -P. 2603-2604.
Jaskiewicz K., Venter F.S., Marasas W.F. Cytopathology of the esophagus in Transkei//JNCI Journal of the National Cancer Institute. -1987. -№ 5 (79). -P. 961-967.
Kaminski M.F., Regula J., Kraszewska E. et al. Quality Indicators for Colonoscopy and the Risk of Interval Cancer//N. Engl. J. Med. -2010. -№ 19 (362). -P 1795-1803.
Katalinic A., Waldmann A., Weinstock M.A. et al. Does skin Cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening//Cancer. -2012. -№ 21 (118). -P. 5395-5402.
Kitahara F., Kobayashi K., Sato T. et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations//Gut. -1999. -№ 5 (44). -P 693697.
Kobayashi H., Yamada Y, Sado T. et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan//International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. -2008. -№ 3 (18). -P. 414-420.
Kubfk A.K., Parkin D.M., Zatloukal P Czech Study on Lung Cancer Screening: post-trial follow-up of lung Cancer deaths up to year 15 since enrollment//Cancer. -2000. -№ 11 Suppl (89). -P. 2363-2368.
Labrie F., Candas B., Cusan L. et al. Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial//The Prostate. -2004. -№ 3 (59). -P. 311-318.
Lee J.K., Liles E.G., Bent S. et al. Accuracy of Fecal Immunochemical Tests for Colorectal Cancer//Annals of Internal Medicine. -2014. -№ 3 (160). -P 171-181-35.
Leinonen M.K., Nieminen P., Lonnberg S. et al. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland//BMJ. -2012. -№ 3 (345). -P. e7789-e7789.
Leja M., You W., Camargo M.C. et al. Implementation of gastric cancer screening -the global experience//Best practice & research. Clinical gastroenterology. -2014. -№ 6 (28). -P. 1093-1106.
Leung W.K., Wu M.-S., Kakugawa Y et al. Screening for gastric cancer in Asia: current evidence and practice//The Lancet Oncology. -2008. -№ 3 (9). -P. 279287.
Lin J.S., Piper M.A., Perdue L.A. et al. Screening for Colorectal Cancer//JAMA. -2016. -№ 23 (315). -P. 2576-19.
Malila N., Leinonen M., Kotaniemi-Talonen L. et al. The HPV test has similar sensitivity but more overdiagnosis than the Pap test-A randomised health services study on cervical cancer screening in Finland//International Journal of Cancer. -2013. -№ 9 (132). -P. 2141-2147.
Manser R., Lethaby A., Irving L.B., et al. Screening for lung cancer//The Cochrane database of systematic reviews. -2013. -№ 6. -P. CD001991.
McMahon B.J., Bulkow L., Harpster A., et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study//Hepatology (Baltimore, Md.). -2000. -№ 4 Pt 1 (32). -P. 842-846.
Menezes R.J., Roberts H.C., Paul N.S. et al. Lung Cancer screening using low-dose computed tomography in at-risk individuals: The Toronto experience//Lung Cancer. 2010. № 2 (67). P. 177-183.
Moore L.E., Pfeiffer R.M., Zhang Z., et al. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian Cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial//Cancer. -2012. -№ 1 (118). -P 91-100.
Myers E.R., Moorman P, Gierisch J.M. et al. Benefits and Harms of Breast Cancer Screening: A Systematic Review//JAMA. -2015. -№ 15 (314). -P 16151634.
Nash F.A., Morgan J.M., Tomkins J.G. South London Lung Cancer Study//British medical journal. -1968. -№ 5607 (2). -P 715-721.
Ohata H., Oka M., Yanaoka K., et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography//Cancer science. -2005. -№ 10 (96). -P. 713-720.
Oken M.M., Hocking W.G., Kvale PA., et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial//JAMA. -2011. -№ 17 (306). -P 1865-1873.
Palma A., Lounsbury D.W., Schlecht N.F., et al. A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer//American Journal of Epidemiology. -2016. -№ 3 (183). -P 227-236.
Patz E.F., Goodman PC., Bepler G. Screening for lung cancer//New England Journal of Medicine. -2000. -№ 22 (343). -P 1627-1633.
Peirson L., Fitzpatrick-Lewis D., Ciliska D. et al. Screening for cervical cancer: a systematic review and meta-analysis//Systematic Reviews. -2013. -№ 1 (2). -P. 35.
Peterson M.S., Baron R.L., Marsh J.W., et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation//Radiology. -2000. -№ 3 (217). -P. 743-749.
Pinsky P.F., Church T.R., Izmirlian G. et al. The National Lung Screening Trial: Results stratified by demographics, smoking history, and lung Cancer histology//Cancer. -2013. -№ 22 (119). -P 3976-3983.
Pinsky P.F., Gierada D.S., Black W. et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment//Annals of Internal Medicine. -2015. -№ 7 (162).-P. 485-491.
Pinsky P.F., Yu K., Kramer B.S. et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up//Gynecologic Oncology. -2016. -№ 2 (143). -P. 270-275.
Pitkaniemi J., Seppa K., Hakama M. et al. Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland//BMJ open gastroenterology. -2015. -№ 1 (2). -P. e000034.
Pritchard K.I. Screening for endometrial cancer: is it effective?//Annals of Internal Medicine. -1989. -№ 3 (110). -P 177-179.
Riecken B., Pfeiffer R., Ma J.L. et al. No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk//Preventive medicine. -2002. -№ 1 (34). -P. 22-28.
Ronco G., Dillner J., Elfstrom K.M. et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials//Lancet (London, England). -2014. -№ 9916 (383). -P. 524-532.
Sankaranarayanan R., Esmy P.O., Rajkumar R., et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial//Lancet (London, England). -2007. -№ 9585 (370). -P. 398-406.
Sankaranarayanan R., Nene B.M., Shastri S.S. et al. HPV screening for cervical cancer in rural India//New England Journal of Medicine. -2009. -№ 14 (360). -P. 1385-1394.
Sankaranarayanan R., Ramadas K., Thara S., et al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India//Oral oncology. -2013. -№ 4 (49). -P. 314-321.
Sasieni P., Castanon A., Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data//BMJ. -2009. -№ 2 (339). -P. b2968-b2968.
Schilling F.H., Spix C., Berthold F., et al. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany//Cancer letters. -2003. -№ 1-2 (197). -P. 19-28.
Schroder F.H., Hugosson J., Roobol M.J. et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up//Lancet (London, England). -2014. -№ 9959 (384). -P. 2027-2035.
Semiglazov V.F., Sagaidak V.N., Moiseyenko V.M. et al. Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study.//European Journal of Cancer. -1992. -№ 14 (29). -P. 2039-2046.
Shaukat A., Mongin S.J., Geisser M.S. et al. Longterm mortality after screening for colorectal cancer//New England Journal of Medicine. -2013. -№ 12 (369). -P. 1106-1114.
Shea M.W. A proposal for a targeted screening program for renal cancer//Frontiers in oncology. -2013. -Vol. 3. -P. 207.
Shen O., Liu S.F., Dawsey S.M. et al. Cytologic screening for esophageal cancer: results from 12,877 subjects from a high-risk population in China//International Journal of Cancer. -1993. -№ 2 (54). -P. 185-188.
Shieh Y, Eklund M., Madlensky L. et al. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial//JNCI Journal of the National Cancer Institute. -2017. -№ 5 (109). -P. djw290.
Smith-Bindman R., Weiss E., Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding//Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. -2004. -№ 5 (24). -P. 558-565.
Sone S., Li F., Yang Z.G. et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner//British Journal of Cancer. -2001. -№ 1 (84). -P. 25-32.
Sozzi G., Boeri M. Potential biomarkers for lung cancer screening//Translational lung cancer research. -2014. -№ 3 (3). -P. 139-148.
Stewart B., Wild, C.P. (eds.) International Agency for Research on Cancer, WHO World Cancer Report 2014 2014.
Su W.W.-Y, Yen A.M.-F., Chiu S.Y-H. et al. A community-based RCT for oral cancer screening with toluidine blue//Journal of dental research. -2010. -№ 9 (89). -P. 933-937.
Swensen S.J., Jett J.R., Hartman T.E. et al. Lung cancer screening with CT: Mayo Clinic experience//Radiology. -2003. -№ 3 (226). -P. 756-761.
Tanner N.T., Kanodra N.M., Gebregziabher M. et al. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial//American Journal of Respiratory and Critical Care Medicine. -2016. -№ 5 (193). -P. 534-541.
Team T.N.L.S.T.R. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening, 2011. -P. 1-15.
Tim L.O., Leiman G., Segal I. et al. A suction-abrasive cytology tube for the diagnosis of esophageal carcinoma//Cancer. -1982. -№ 4 (50). -P. 782-784.
van der Aa M.A., Pukkala E., Coebergh J.W.W. et al. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands//International Journal of Cancer. -2007. -№ 8 (122). -P. 1854-1858.
Wei W.-Q., Chen Z.-F., He Y-T. et al. Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China//Journal of clinical oncology: official journal of the American Society of Clinical Oncology. -2015. -№ 17 (33). -P. 1951-1957.
Weiss V.L., Cate F., Bloom L. et al. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years//Cytopathol-ogy. -2016. -№ 4 (27). -P. 242-248.
Weiss W., Boucot K.R. The Philadelphia Pulmonary Neoplasm Research Project. Early roentgenographic appearance of bronchogenic carcinoma//Archives of internal medicine. -1974. -№ 2 (134). -P. 306-311.
Wernli K.J., Henrikson N.B., Morrison C.C. et al. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force//JAMA. -2016. -№ 4 (316). -P. 436447.
Wilson J.M.G., Jungner G. Principles and practice of screening for disease//WHO. Public Health Paper. -1968. -№ 34.
Wong B.C.-Y, Lam S.K., Wong W.M. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial//JAMA. -2004. -№ 2 (291). -P. 187-194.
Woods W.G., Tuchman M., Robison L.L. et al. A population-based study of the usefulness of screening for neuroblastoma//The Lancet. -1996. -№ 9043 (348). -P. 1682-1687.
Wun YT., Dickinson J.A. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B//The Cochrane database of systematic reviews. -2003. -№ 2. -P. CD002799.
Yamamoto K., Hanada R., Kikuchi A. et al. Spontaneous regression of localized neuroblastoma detected by mass screening//Journal of Clinical Oncology. -1998. -№ 4 (16).-P. 1265-1269.
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2017